Goldman Sachs’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,616,785
| Closed | -$23.8M | – | 6540 |
|
|
2025
Q3 | $23.8M | Buy |
1,616,785
+363,700
| +29% | +$3.71M | ﹤0.01% | 2101 |
|
|
2025
Q2 | $12.3M | Buy |
1,253,085
+257,636
| +26% | +$2.13M | ﹤0.01% | 2573 |
|
|
2025
Q1 | $7.24M | Buy |
995,449
+188,367
| +23% | +$1.65M | ﹤0.01% | 2994 |
|
|
2024
Q4 | $6.31M | Buy |
807,082
+73,585
| +10% | +$606K | ﹤0.01% | 3212 |
|
|
2024
Q3 | $5.43M | Sell |
733,497
-171,320
| -19% | -$1.44M | ﹤0.01% | 3271 |
|
|
2024
Q2 | $7.25M | Buy |
904,817
+159,869
| +21% | +$1.43M | ﹤0.01% | 2819 |
|
|
2024
Q1 | $8.67M | Buy |
744,948
+113,836
| +18% | +$1.26M | ﹤0.01% | 2598 |
|
|
2023
Q4 | $7.05M | Buy |
631,112
+112,438
| +22% | +$1.03M | ﹤0.01% | 2844 |
|
|
2023
Q3 | $8.01M | Sell |
518,674
-96,493
| -16% | -$1.62M | ﹤0.01% | 2582 |
|
|
2023
Q2 | $11.7M | Buy |
615,167
+146,976
| +31% | +$2.58M | ﹤0.01% | 2306 |
|
|
2023
Q1 | $7.13M | Sell |
468,191
-191,733
| -29% | -$2.5M | ﹤0.01% | 2722 |
|
|
2022
Q4 | $8.4M | Buy |
659,924
+271,344
| +70% | +$2.44M | ﹤0.01% | 2730 |
|
|
2022
Q3 | $2.25M | Buy |
388,580
+302,519
| +352% | +$1.33M | ﹤0.01% | 3882 |
|
|
2022
Q2 | $277K | Buy |
86,061
+16,025
| +23% | +$48.4K | ﹤0.01% | 5472 |
|
|
2022
Q1 | $264K | Buy |
70,036
+59,791
| +584% | +$385K | ﹤0.01% | 5731 |
|
|
2021
Q4 | $134K | Buy |
+10,245
| New | +$162K | ﹤0.01% | 6040 |
|
|
2021
Q3 | – | Sell |
-12,525
| Closed | -$234K | – | 6306 |
|
|
2021
Q2 | $234K | Sell |
12,525
-12,106
| -49% | -$270K | ﹤0.01% | 5667 |
|
|
2021
Q1 | $583K | Buy |
24,631
+15,536
| +171% | +$359K | ﹤0.01% | 5005 |
|
|
2020
Q4 | $222K | Buy |
+9,095
| New | +$233K | ﹤0.01% | 5041 |
|
|
2020
Q1 | – | Sell |
-22,836
| Closed | -$600K | – | 5295 |
|
|
2019
Q4 | $600K | Buy |
+22,836
| New | +$635K | ﹤0.01% | 4400 |
|
Other funds holding ETNB
Goldman Sachs's ETNB Position: Q4 2025 in Review
Goldman Sachs sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,616,785 shares — an estimated $23.8M sold.
Goldman Sachs first reported a position in ETNB in Q4 2019 and held it in 20 quarters. The position peaked at $23.8M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Goldman Sachs reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Goldman Sachs sold 1,616,785 89bio shares in Q4 2025, an estimated $23.8M.
- Goldman Sachs first reported a position in 89bio in Q4 2019 and held it in 20 quarters.
- Goldman Sachs's 89bio position peaked at $23.8M in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.